CAMBRIDGE, Mass. --(BUSINESS WIRE)--Aug. 7, 2020-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its second quarter 2020 financial results for the period ended June 30, 2020 . “We are pleased by recent news releases from both Ipsen Pharmaceuticals and